首页>
外文期刊>国际肝胆胰疾病杂志(英文版)
>Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virusinfection
【24h】
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virusinfection
To the Editor:I have previously reported a type II diabetic patient complicated with chronic hepatitis C virus(HCV)infection.1]Recently,Riva et al[2]reported an association of truncated CXCL10 with failure to achieve spontaneous clearance of acute HCV infection.They showed
展开▼